RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for RECURRENT SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets tough blood cancers
Disease control CompletedThis study tested whether combining two drugs could help people with certain blood cancers that had returned after previous treatment or were newly diagnosed. The trial included 41 adults with chronic lymphocytic leukemia or similar conditions. Researchers gave participants an an…
Matched conditions: RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test new combo attack on stubborn blood cancers
Disease control CompletedThis early-stage study tested a new combination of two drugs, lenalidomide and blinatumomab, for people with non-Hodgkin lymphoma that had come back or stopped responding to other treatments. The main goal was to find the safest and most effective dose of the drugs when used toge…
Matched conditions: RECURRENT SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC